Evidence map›Paper›PMID 24997584›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2014

Serum adenosine deaminase activity in cutaneous anthrax.

Mahmut Sunnetcioglu, Sevdegul Karadas, Mehmet Aslan, Mehmet Resat Ceylan, Halit Demir, Mehmet Resit Oncu, Mustafa Kasım Karahocagil, Aysel Sunnetcioglu, Cenk Aypak

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Serum Adenosine Deaminase as a Useful Marker to Estimate Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mahmut SunnetciogluDepartment of Infectious Diseases and Clinical Microbiology, Yuzuncu Yil University, Faculty of Medicine, Van, Turkey.
Sevdegul KaradasDepartment of Emergency Medicine, Yuzuncu Yil University, Faculty of Medicine, Van, Turkey.
Mehmet AslanDepartment of Infectious Diseases and Clinical Microbiology, Yuzuncu Yil University, Faculty of Medicine, Van, Turkey.
Mehmet Resat CeylanDepartment of Infectious Diseases and Clinical Microbiology, Yuzuncu Yil University, Faculty of Medicine, Van, Turkey.
Halit DemirDepartment of Chemistry, Yuzuncu Yil University, Faculty of Science and Art, Van, Turkey.
Mehmet Resit OncuDepartment of Emergency Medicine, Yuzuncu Yil University, Faculty of Medicine, Van, Turkey.
Mustafa Kasım KarahocagilDepartment of Infectious Diseases and Clinical Microbiology, Yuzuncu Yil University, Faculty of Medicine, Van, Turkey.
Aysel SunnetciogluDepartment of Pulmonary Diseases, Yuzuncu Yil University, Faculty of Medicine, Van, Turkey.
Cenk AypakDepartment of Family Medicine, Dıskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdenosine deaminase (ADA) activity has been discovered in several inflammatory conditions; however, there are no data associated with cutaneous anthrax. The aim of this study was to investigate serum ADA activity in patients with cutaneous anthrax. MATERIAL AND

methodsSixteen patients with cutaneous anthrax and 17 healthy controls were enrolled. We measured ADA activity; peripheral blood leukocyte, lymphocyte, neutrophil, and monocyte counts; erythrocyte sedimentation rate; and C reactive protein levels.

resultsSerum ADA activity was significantly higher in patients with cutaneous anthrax than in the controls (p<0.001). A positive correlation was observed between ADA activity and lymphocyte counts (r=0.589, p=0.021) in the patient group.

conclusionsThis study suggests that serum ADA could be used as a biochemical marker in cutaneous anthrax.

Indexed as

Adenosine DeaminaseAdultAnthraxCase-Control StudiesDemographyFemaleHumansMaleSkin Diseases, BacterialADA protein, humanAdenosine Deaminase

Identifiers

PMID24997584
PMCPMC4099211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.